Sublingual Formulations News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sublingual formulations. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sublingual Formulations Today - Breaking & Trending Today

XORTX Therapeutics Inc.: XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease

XORTX Therapeutics Inc.: XORTX Submits a New Patent for the Treatment of Chronic Kidney Disease
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United States , Allen Davidoff , Nick Rigopulos , Therapeutics Inc , Company Xrx , Sublingual Formulations , Xanthine Oxidase Inhibitors , Bridging Pharmacokinetic Study , Kidney Disease , Polycystic Kidney Disease , Nat Rev Dis , Nat Rev Nephrol , Respiratory Viral ,

XORTX Announces Submission Of Patent For Treatment Of Chronic Kidney Disease

XORTX Therapeutics Inc. (XRTX) announced submission of a new patent for the treatment of chronic kidney disease. The patent entitled "Oral and Sublingual Formulations of Xanthine Oxidase Inhibitors and Methods of Treating Disease" outlines new formulations and methods for safer and more effective the use of xanthine oxidase inhibitors in the setting of chronic kidney disease in particular autosomal dominant polycystic kidney disease, diabetic nephropathy, IgA nephropathy, lupus nephritis and focal segmental glomerulosclerosis. ....

Allen Davidoff , More Such Health News , Therapeutics Inc , Sublingual Formulations , Xanthine Oxidase Inhibitors , Xortx Therapeutics ,